
Avecho Biotechnology dosed 244 patients in its phase III insomnia trial, 16% above target, in a […]
The post Financial news in brief: Avecho CBD trial latest; Argent’s milestone delivery; Neurotech reassures ASX appeared first on Cannabiz.
Continue reading...